ARCHIVES

Ungerleider To Leave NCI For Theradex Corp.

This article is from The Cancer Letter archive.

Vol. 26 No. 43 | November 24, 2000

Download PDF Visit The Full Archive

Related Articles

Congress Passes FDA User Fee Bill, Averting Layoffs.

September 21, 2007

HHS Proposes Six New DRGs for Leukemia, Lymphoma

July 4, 1986

Richard Pazdur’s Comments to ODAC

July 22, 2011

Cediranib Demonstates Control In Alveolar Soft Part Sarcoma

May 31, 2013

Mammography Hazard In ACS-NCI Screening Charged

October 17, 1975

In Brief: MDA Treats Only 9% Of Texas Cancer Patients; Clinical Director Search Narrows To Three

March 12, 1976